4//SEC Filing
Barclay Alec 4
Accession 0000899243-22-012779
CIK 0001492674other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:00 PM ET
Size
8.7 KB
Accession
0000899243-22-012779
Insider Transaction Report
Form 4
Barclay Alec
SVP, Operations
Transactions
- Exercise/Conversion
Common Stock
2022-03-14+21,666→ 180,421 total - Tax Payment
Common Stock
2022-03-14$0.36/sh−11,428$4,160→ 168,993 total - Exercise/Conversion
Restricted Stock Units
2022-03-14−21,666→ 21,667 total→ Common Stock (21,666 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]11,428 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On March 14, 2020 the reporting person was granted 65,000 that vest in three equal annual installments commencing on March 14, 2021.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001734339
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:00 PM ET
- Size
- 8.7 KB